No survival benefit with androgen suppression: study

In a retrospective cohort study of 15,000 newly diagnosed men, the researchers found no significant differences in risk of all-cause mortality, prostate cancer-specific mortality or cardiovascular mortality between those receiving PADT and those not receiving it.

# Tags